SOTERIA - An Open-Label Long-Term Follow-Up Study to Evaluate the Effects of Sotatercept when Added to Background Pulmonary Arterial Hypertension (PAH) Therapy for the Treatment of PAH
-
Enrollment
This study is currently enrolling. -
Associated Conditions
-
Research Area
Heart, Lung and Vascular Research -
Location
-
Principal Investigator
-
Sponsor
Accerleron Pharma
We are asking you to take part in this study because you are currently in a study with sotatercept and we want to find out if continuing to take sotatercept is safe and effective over a long period of time.
Enrollment Form
This study is currently enrolling.